EuroEspes S.A [EEP] vs Clinica Baviera S.A [CBAV] Detailed Stock Comparison
EuroEspes S.A
BME
Loading...
Clinica Baviera S.A
BME
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: EuroEspes S.A wins in 4 metrics, Clinica Baviera S.A wins in 7 metrics, with 0 ties. Clinica Baviera S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | EuroEspes S.A | Clinica Baviera S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 18.29 | N/A |
| Price-to-Book Ratio | N/A | 7.89 | N/A |
| Debt-to-Equity Ratio | 0.70 | 70.72 | EuroEspes S.A |
| PEG Ratio | N/A | 24.94 | N/A |
| EV/EBITDA | -24.17 | 9.48 | EuroEspes S.A |
| Profit Margin (TTM) | 91.78% | 13.51% | EuroEspes S.A |
| Operating Margin (TTM) | -64.77% | 19.71% | Clinica Baviera S.A |
| EBITDA Margin (TTM) | N/A | 19.71% | N/A |
| Return on Equity | -73.83% | 46.33% | Clinica Baviera S.A |
| Return on Assets (TTM) | -26.90% | 16.56% | Clinica Baviera S.A |
| Free Cash Flow (TTM) | $32,790 | $36.00M | Clinica Baviera S.A |
| Dividend Yield | N/A | 7.97% | N/A |
| 1-Year Return | 0.00% | 52.96% | Clinica Baviera S.A |
| Price-to-Sales Ratio (TTM) | 2.12 | 2.43 | EuroEspes S.A |
| Enterprise Value | $9.87M | $740.84M | Clinica Baviera S.A |
| EV/Revenue Ratio | 3.34 | 2.56 | Clinica Baviera S.A |
| Revenue per Share (TTM) | N/A | $18 | N/A |
| Earnings per Share (Diluted) | N/A | $2.40 | N/A |
| Beta (Stock Volatility) | N/A | 0.80 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
EuroEspes S.A vs Clinica Baviera S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| EuroEspes S.A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Clinica Baviera S.A | -0.23% | -1.13% | 0.69% | 17.69% | 25.43% | 39.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| EuroEspes S.A | 0.00% | 3.85% | 35.00% | -5.26% | -59.70% | -59.70% |
| Clinica Baviera S.A | 52.96% | 113.11% | 393.26% | 642.81% | 772.76% | 772.76% |
Performance & Financial Health Analysis: EuroEspes S.A vs Clinica Baviera S.A
| Metric | EEP | CBAV |
|---|---|---|
| Market Information | ||
| Market Cap | €6.26M | €702.98M |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 28 | 5,746 |
| 90 Day Avg. Volume | 3 | 6,962 |
| Last Close | €0.54 | €43.90 |
| 52 Week Range | €0.54 - €0.54 | €28.30 - €45.40 |
| % from 52W High | 0.00% | -3.30% |
| All-Time High | €2.45 (Jan 20, 2014) | €45.40 (Jul 16, 2025) |
| % from All-Time High | -77.96% | -3.30% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.12% |
| Quarterly Earnings Growth | N/A | -0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.92% | 0.14% |
| Operating Margin (TTM) | -0.65% | 0.20% |
| Return on Equity (TTM) | -0.74% | 0.46% |
| Debt to Equity (MRQ) | 0.70 | 70.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | €5.57 |
| Cash per Share (MRQ) | N/A | €2.43 |
| Operating Cash Flow (TTM) | €-1,014,670 | €66.67M |
| Levered Free Cash Flow (TTM) | €-2,134,091 | €5.07M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 7.97% |
| Last 12-Month Dividend | N/A | €3.14 |
Valuation & Enterprise Metrics Analysis: EuroEspes S.A vs Clinica Baviera S.A
| Metric | EEP | CBAV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 18.29 |
| Forward P/E | N/A | 24.94 |
| PEG Ratio | N/A | 24.94 |
| Price to Sales (TTM) | 2.12 | 2.43 |
| Price to Book (MRQ) | N/A | 7.89 |
| Market Capitalization | ||
| Market Capitalization | €6.26M | €702.98M |
| Enterprise Value | €9.87M | €740.84M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.34 | 2.56 |
| Enterprise to EBITDA | -24.17 | 9.48 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.80 |
| Book Value per Share (MRQ) | N/A | €5.57 |
Financial Statements Comparison: EuroEspes S.A vs Clinica Baviera S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EEP | CBAV |
|---|---|---|
| Revenue/Sales | N/A | €74.52M |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | €14.80M |
| EBITDA | N/A | €20.65M |
| Pre-Tax Income | N/A | €14.36M |
| Income Tax | N/A | €4.42M |
| Net Income (Profit) | N/A | €9.94M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EEP | CBAV |
|---|---|---|
| Cash & Equivalents | €971,101 | €53.44M |
| Total Current Assets | €1.97M | €63.13M |
| Total Current Liabilities | €2.56M | €53.07M |
| Long-Term Debt | €2.60M | €61.13M |
| Total Shareholders Equity | €6.20M | €111.40M |
| Retained Earnings | €-1.14M | N/A |
| Property, Plant & Equipment | €10.48M | €123.74M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EEP | CBAV |
|---|---|---|
| Operating Cash Flow | N/A | €18.06M |
| Capital Expenditures | N/A | €-5.15M |
| Free Cash Flow | N/A | €19.12M |
| Debt Repayment | N/A | €-857,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EEP | CBAV |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 28 | 5,746 |
| Average Daily Volume (90 Day) | 3 | 6,962 |
| Shares Outstanding | 11.61M | 15.99M |
| Float Shares | N/A | 2.44M |
| % Held by Insiders | N/A | 0.85% |
| % Held by Institutions | N/A | 0.05% |
Dividend Analysis & Yield Comparison: EuroEspes S.A vs Clinica Baviera S.A
| Metric | EEP | CBAV |
|---|---|---|
| Last 12-Month Dividend | N/A | €3.14 |
| Last 12-Month Dividend Yield | N/A | 7.97% |
| 3-Year Avg Annual Dividend | N/A | €1.48 |
| 3-Year Avg Dividend Yield | N/A | 4.15% |
| 3-Year Total Dividends | N/A | €4.44 |
| Ex-Dividend Date | N/A | Jun 11, 2025 |